HCM III Acquisition Corp

HCM III Acquisition Corp(HCMA)股票分析

$10.290

0.000 (0.00%)收盤時

Loading chart…
最高
10.290
開盤
10.290
成交量加權均價
10.29
成交量
299.92K
市值
205.06M
最低
10.290
成交金額
3.09M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

HCM III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination in any business or industry. It has no operations and has not generated any revenue.

AI 分析 of HCM III Acquisition Corp (HCMA)

持有

Currently, HCM III Acquisition Corp (HCMA) is not a strong buy due to its low RSI of 37.67, indicating it is nearing oversold territory, and a high P/E ratio of 64.13, suggesting it may be overvalued. While the stock has shown a slight year-to-date change of +2.18%, the lack of significant positive catalysts and the neutral stance from insiders and hedge funds indicate caution. The main risk is the current ratio of 0.51, which suggests potential liquidity issues.

估值指標

HCM III Acquisition Corp(HCMA)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

持有 HCMA 的大戶

L

Linden Advisors LP

+ 持有HCMA

+57.91%

3個月報酬率

事件時間軸

2025-07-31 (ET)

21:41:07

HCM Acquisition prices 22M unit IPO at $10 per unit

資訊

HCMA 常見問題 —— 由 Alphio AI 解答

HCM III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination in any business or industry. It has no operations and has not generated any revenue. It operates in the Financials sector (BLANK CHECKS industry).

Currently, HCM III Acquisition Corp (HCMA) is not a strong buy due to its low RSI of 37.67, indicating it is nearing oversold territory, and a high P/E ratio of 64.13, suggesting it may be overvalued. While the stock has shown a slight year-to-date change of +2.18%, the lack of significant positive catalysts and the neutral stance from insiders and hedge funds indicate caution. The main risk is the current ratio of 0.51, which suggests potential liquidity issues.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易